Concepedia

Robert L. Kampen

RL

Statistics

Publications

15

Citations

2.4K

H-Index

15

Active since

1999

Affiliations

Walter Reed Army Institute of Research(Current)

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Biogen (United States)

Naval Medical Research Command

Robert L. Kampen is an author at Walter Reed Army Institute of Research specializing in medicine, immunology, and transplantation.

Top concepts

Publications per year

1999–2009

15

Publications

15

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

Allan D. Kirk, Linda C. Burkly, D. Scott Batty et al. · Nature Medicine · 1999 · 824 citations

, , +13

RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)

Allan D. Kirk, Douglas A. Hale, Roslyn B. Mannon et al. · Transplantation · 2003 · 436 citations

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

Marinos C. Dalakas, Goran Rakočević, Jan Schmidt et al. · Brain · 2009 · 201 citations · Full text

Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates

Tim Weaver, Ali H. Charafeddine, Avinash Kumar Ágarwal et al. · Nature Medicine · 2009 · 185 citations · Full text

, , +11

Functionally Significant Renal Allograft Rejection Is Defined by Transcriptional Criteria

Steven C. Hoffmann, Douglas A. Hale, David E. Kleiner et al. · American Journal of Transplantation · 2005 · 135 citations · Full text

1–5 of 15